Loading...

Awakn Life Sciences Corp.

AWKN.NE•NEO
Healthcare
Biotechnology
CA$0.10
CA$-0.04(-25.93%)

Awakn Life Sciences Corp. (AWKN.NE) Stock Overview

Explore Awakn Life Sciences Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 59.8/100

Key Financials

Market Cap3.9M
P/E Ratio-0.28
EPS (TTM)$-0.28
ROE-4.29%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.05

AWKN.NE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Awakn Life Sciences Corp. (AWKN.NE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.05.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.28 and a market capitalization of 3.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for AWKN.NEStats details for AWKN.NE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for AWKN.NEAnalyst Recommendations details for AWKN.NE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company is headquartered in Toronto, Canada.

CEO

Anthony Tennyson

Employees

44

Headquarters

301-217 Queen Street West, Toronto, ON

Founded

2021

Frequently Asked Questions

;